(ARCT) Arcturus Therapeutics - Performance -42% in 12m
ARCT performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
-76.48%
#121 in Peer-Group
Rel. Strength
12.09%
#6737 in Stock-Universe
Total Return 12m
-42.00%
#114 in Peer-Group
Total Return 5y
-72.69%
#86 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 2.48 |
| High / Low | USD |
|---|---|
| 52 Week High | 25.48 USD |
| 52 Week Low | 8.91 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 79.14 |
| Buy/Sell Signal +-5 | -1.22 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: ARCT (-42%) vs XBI (-11.1%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
1.02% | 61.8% | 74.7% | 23.5 | 14.1 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
6.89% | -8.76% | 155% | 12 | 11 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
1.19% | -6.24% | 38% | 27.2 | 14.2 | 0.99 | 0.60% | 41% |
| BIM PA Biomerieux |
-2.29% | 26.9% | -2.56% | 32.7 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
7.48% | -8.9% | 5.85% | 45.7 | 26.2 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
11.5% | 27.6% | -6.21% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.47% | 46.2% | -8.05% | 7.54 | 6.09 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
1.64% | 26.9% | 19% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: ARCT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARCT
| Total Return (including Dividends) | ARCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 10.77% | 3.15% | 4.01% |
| 3 Months | 42.06% | 17.08% | 17.14% |
| 12 Months | -42.00% | -11.14% | 13.46% |
| 5 Years | -72.69% | -21.96% | 112.73% |
| Trend Score (consistency of price movement) | ARCT | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 77.1% | 52.1% | 90.3% |
| 3 Months | 69.6% | 79.4% | 97.5% |
| 12 Months | -90.1% | -87.4% | 46.4% |
| 5 Years | -66.3% | -52.1% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th77.00 | 7.39% | 6.50% |
| 3 Month | %th73.00 | 21.33% | 21.27% |
| 12 Month | %th43.00 | -34.73% | -48.88% |
| 5 Years | %th57.50 | -65.01% | -87.16% |
FAQs
Does Arcturus Therapeutics (ARCT) outperform the market?
No,
over the last 12 months ARCT made -42.00%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.14%.
Over the last 3 months ARCT made 42.06%, while XBI made 17.08%.
Performance Comparison ARCT vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
ARCT vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 2.7% | 6.8% | -28.3% | -55% |
| US NASDAQ 100 | QQQ | 2.8% | 6.6% | -30.3% | -55% |
| German DAX 40 | DAX | 2.3% | 9.6% | -40.4% | -72% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.5% | 6.2% | -32.7% | -61% |
| Hongkong Hang Seng | HSI | 1.8% | 7.9% | -50.3% | -77% |
| India NIFTY 50 | INDA | 4% | 11.6% | -28.7% | -39% |
| Brasil Bovespa | EWZ | 6.9% | 11.4% | -43.3% | -43% |
ARCT vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 4.1% | 9.1% | -31.6% | -66% |
| Consumer Discretionary | XLY | 1.8% | 7.4% | -20.6% | -60% |
| Consumer Staples | XLP | 4.7% | 10.9% | -27.4% | -49% |
| Energy | XLE | -0.3% | 6.6% | -20.7% | -44% |
| Financial | XLF | 4.1% | 8.1% | -30.6% | -67% |
| Health Care | XLV | 2.5% | 10.7% | -16.8% | -35% |
| Industrial | XLI | 2.3% | 6.3% | -34.1% | -65% |
| Materials | XLB | 2% | 6.3% | -28.9% | -46% |
| Real Estate | XLRE | 2.9% | 10.9% | -26.8% | -50% |
| Technology | XLK | 2.8% | 4.1% | -33.4% | -53% |
| Utilities | XLU | 2.6% | 8.2% | -32.3% | -62% |
| Aerospace & Defense | XAR | 2% | 3.9% | -48.3% | -91% |
| Biotech | XBI | -1% | 7.6% | -18% | -31% |
| Homebuilder | XHB | -0.4% | 2% | -21.7% | -41% |
| Retail | XRT | 2.7% | 7.5% | -23.5% | -48% |
ARCT vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 2.1% | 7.47% | -14.4% | -37% |
| Natural Gas | UNG | 4.4% | 17.2% | -2.3% | -40% |
| Gold | GLD | 2.6% | 10.5% | -46.2% | -80% |
| Silver | SLV | -1.7% | 4.5% | -50.3% | -64% |
| Copper | CPER | -7.7% | -4.2% | -47.8% | -65% |
ARCT vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 3.6% | 10.8% | -23% | -38% |
| iShares High Yield Corp. Bond | HYG | 3.2% | 9.6% | -25.3% | -51% |